Sayaka Shimada — HTGAA Spring 2026

About me
I’m a contemporary artist working with fireworks, water, and moving image.
I’m a PhD candidate at Tokyo University of the Arts, graduating in March 2026. ;)

I’m a contemporary artist working with fireworks, water, and moving image.
I’m a PhD candidate at Tokyo University of the Arts, graduating in March 2026. ;)
Week 1 HW: Principles and Practices
Documentation Class Assignment — DUE BY START OF FEB 10 LECTURE 1. First, describe a biological engineering application or tool you want to develop and why. This could be inspired by an idea for your HTGAA class project and/or something for which you are already doing in your research, or something you are just curious about. I have a deep interest in Japanese fireworks culture and have incorporated fireworks into my artistic practice. In Japan, fireworks have long carried meanings of memorialization and life, making transience and cyclic time a shared embodied experience. At the same time, contemporary conditions—environmental footprint and responsible deployment—ask us to rethink what fireworks can mean today.
I have a deep interest in Japanese fireworks culture and have incorporated fireworks into my artistic practice. In Japan, fireworks have long carried meanings of memorialization and life, making transience and cyclic time a shared embodied experience. At the same time, contemporary conditions—environmental footprint and responsible deployment—ask us to rethink what fireworks can mean today.
This project relocates the ideas that fireworks have historically held—one-time temporality, memorialization, and the bodily experience of light—into bio-art. Instead of treating an explosion as the engine, I treat a molecular-biology-inspired sensing→processing→reporting interface as the engine, producing a time-varying signal I call a “breathing” glow.
Conceptually, the work draws on gene-expression logic (signals that turn on, intensify, and shift over time) to imagine a living light interface: softly modulated patterns of light or color that evoke the pulse of living systems. The tool is intended to render biological rhythms and environmental changes as a poetic, legible experience of time.
Note: This is a conceptual art-research proposal and intentionally avoids procedural detail. Any implementation would require expert oversight, appropriate review, and clear public communication to prevent misinterpretation.
Purpose (what changes):
Currently, decisions can be ad hoc and person-dependent. I propose a standardized pre-deployment review that makes safety, environmental, and misinterpretation risks explicit before any public display.
Design (what’s needed; who acts):
Assumptions (what could be wrong):
Risks of failure & “success”:
Purpose (what changes):
Public-facing bio-art can be misread as scientific diagnosis or certification. I propose a communication standard that reduces misinformation risk while preserving artistic intent.
Design (what’s needed; who acts):
Assumptions (what could be wrong):
Risks of failure & “success”:
Purpose (what changes):
Containment, cleanup, and end-of-life handling are often unclear in public art contexts. I propose a containment-first design principle and an explicit disposal/recovery protocol.
Design (what’s needed; who acts):
Assumptions (what could be wrong):
Risks of failure & “success”:
| Does the option… | Safety case + accountability | Communication standard | Containment+disposal protcol |
|---|---|---|---|
| Enhance Biosecurity | |||
| • By preventing incidents | 2 | 3 | 2 |
| • By helping respond | 1 | 3 | 2 |
| Foster Lab / Handling Safety | |||
| • By preventing incidents | 2 | 3 | 1 |
| • By helping respond | 1 | 3 | 2 |
| Protect the environment | |||
| • By preventing incidents | 2 | 3 | 1 |
| • By helping respond | 2 | 3 | 1 |
| Other considerations | |||
| • Minimizing costs and burdens to stakeholders | 2 | 1 | 3 |
| • Feasibility ? | 2 | 1 | 2 |
| • Not impede research | 2 | 1 | 2 |
| • Promote constructive applications | 1 | 2 | 2 |
| Prevent military / harmful repurposing | 2 | 3 | 2 |
Recommendation:
I would prioritize Action 1 (pre-deployment “safety case” + clear accountability) and Action 3 (containment + disposal protocol) as the baseline, and require Action 2 (communication standard) for every public-facing display.
Why:
Action 1 and 3 most directly reduce biosafety and environmental risks, while Action 2 reduces misinterpretation and protects public trust.
Trade-offs:
Stronger safeguards can increase cost and slow iteration, and may raise barriers for smaller projects. Clear communication can also reduce ambiguity, which is sometimes part of the artwork.
Assumptions / uncertainties:
Technical feasibility and long-term impacts are uncertain, so governance should be staged (start small, learn, then scale) and updated based on evidence.
Audience:
Museum/festival leadership and safety officers; university review boards for art–science collaborations; relevant national regulators.
1. Nature’s machinery for copying DNA is called polymerase. What is the error rate of polymerase? How does this compare to the length of the human genome. How does biology deal with that discrepancy? (polymeraseのエラー率は?人間ゲノムの長さと比べると?そのズレを生物はどう解決するか)
Reference URL:
https://pmc.ncbi.nlm.nih.gov/articles/PMC4267634
https://www.genome.gov/genetics-glossary
https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/dna-mismatch-repair
https://www.nature.com/scitable/topicpage/dna-replication-and-causes-of-mutation-409/
Biology resolves this discrepancy using layered fidelity mechanisms…
Together, these steps reduce the effective mutation rate to ~10-9–10-10 per base pair.
2. How many different ways are there to code (DNA nucleotide code) for an average human protein? In practice what are some of the reasons that all of these different codes don’t work to code for the protein of interest?
(平均的ヒトタンパク質をコードするDNA配列は何通りあるのか?なぜ全部うまくいかないのか?)
Reference URL:
https://www.sciencedirect.com/science/article/abs/pii/S1046202305000885
https://bionumbers.hms.harvard.edu/bionumber.aspx?id=106445&s=n&v=4
https://pmc.ncbi.nlm.nih.gov/articles/PMC1150220/
https://pmc.ncbi.nlm.nih.gov/articles/PMC4359748/
https://academic.oup.com/nar/article/41/4/2073/2414416
https://pmc.ncbi.nlm.nih.gov/articles/PMC2840511/
https://www.science.org/doi/10.1126/science.1241934
The genetic code is “degenerate”: many amino acids have multiple synonymous codons.
So the same protein can be written in DNA in an astronomically large number of ways (especially for proteins with a few hundred amino acids).
But many synonymous versions don’t work equally well because codon choice can change:
1. What’s the most commonly used method for oligo synthesis currently?
(oligo合成で一番よく使われる方法は?)
Reference URL:
https://atdbio.com/nucleic-acids-book/Solid-phase-oligonucleotide-synthesis
The most commonly used method for oligo synthesis is solid-phase phosphoramidite synthesis.
2. Why is it difficult to make oligos longer than 200nt via direct synthesis?
(なぜ200ntを超えると直接合成が難しい?)
Reference URL:
[段階収率が累積して長鎖が難しい(150nt以上が難しい、0.99^150 の例など)] https://www.nature.com/articles/s42004-024-01216-0
[長いオリゴで脱プリン(depurination)が制限要因になる(LeProust 2010, NAR)] https://academic.oup.com/nar/article/38/8/2522/3112266
[化学反応効率の限界で150–200 basesが上限、エラーが累積(Ma 2012 review, PMC)] https://pmc.ncbi.nlm.nih.gov/articles/PMC3424320/
[ホスホロアミダイト法の限界:~200nt、1サイクル収率の累積(Yoo 2021 review, PMC)] https://pmc.ncbi.nlm.nih.gov/articles/PMC8113751/
[段階収率の計算で実用長が~200ntに制限(ACS Catalysis 2025 PDF)] https://pubs.acs.org/doi/pdf/10.1021/acscatal.5c05189
[「200-merが最長とされる」長鎖の直接合成に挑戦した例(RSC 2025)] https://pubs.rsc.org/en/content/articlelanding/2025/sc/d4sc06958g
Direct chemical oligo synthesis becomes difficult beyond ~200 nt because each nucleotide addition cycle is slightly imperfect, so the full-length yield drops exponentially as length increases. Errors and truncated byproducts accumulate (including side reactions such as depurination), making it hard to obtain high-purity, full-length oligos at longer lengths.
3. Why can’t you make a 2000bp gene via direct oligo synthesis?
(なぜ2000bpを直接合成できない?)
[Synthetic DNA Synthesis and Assembly review; oligos up to ~200 nt; error sources] https://pmc.ncbi.nlm.nih.gov/articles/PMC5204324/
[Gene assembly errors; typical 1–3 errors/kb noted] https://pmc.ncbi.nlm.nih.gov/articles/PMC3347765/
[Gene assembly error rate ranges 1–10 errors/kb] https://currentprotocols.onlinelibrary.wiley.com/doi/10.1002/0471142727.mb0324s99
[Errors largely attributed to oligo synthesis/purity in genome assembly work] https://www.pnas.org/doi/10.1073/pnas.2237126100
[Review noting challenges beyond ~200 bases] https://pmc.ncbi.nlm.nih.gov/articles/PMC8113751/
Direct chemical oligo synthesis adds one nucleotide per cycle, and each cycle is slightly imperfect.
As length increases, the chance of getting a full-length product drops exponentially, so a 2000 bp “one-piece” product becomes essentially impossible to obtain in high purity.
Errors and truncated byproducts accumulate, and purification becomes extremely difficult.
Even if you try to build 2000 bp from many shorter oligos, oligo-derived errors compound across the assembly.
Therefore, long genes are usually made by assembling shorter fragments and then verifying / error-correcting, rather than by direct
Choose ONE of the following three questions to answer; and please cite AI prompts or paper citations used, if any
[Using Google & Prof. Church’s slide #4] What are the 10 essential amino acids in all animals and how does this affect your view of the “Lysine Contingency”?
(すべての動物に存在する10種類の必須アミノ酸とは何か、そしてこれは「リシン・コンティンジェンシー」に対するあなたの見解にどのような影響を与えるか?)
[Given slides #2 & 4 (AA:NA and NA:NA codes)] What code would you suggest for AA:AA interactions?
[(Advanced students)] Given the one paragraph abstracts for these real 2026 grant programs sketch a response to one of them or devise one of your own:
(以下の2026年度助成プログラムの概要(各1段落)に基づき、いずれか一つへの回答を概説するか、あるいは独自の回答を考案してください:)
Lysine contingency?? https://jurassicpark.fandom.com/wiki/Lysine_contingency -lysine contingency : biocontainment idea: an organism is designed to survive only when lysine is supplied from the outside. (リジンがある時だけ生存できる装置のような設計)
Contingency: conditional on / dependent on…lysine-dependent survival